327 related articles for article (PubMed ID: 78050)
1. Dipyridamole and other phosphodiesterase inhibitors act as antithrombotic agents by potentiating endogenous prostacyclin.
Moncada S; Korbut R
Lancet; 1978 Jun; 1(8077):1286-9. PubMed ID: 78050
[TBL] [Abstract][Full Text] [Related]
2. The role of prostacyclin in vascular tissue.
Moncada S; Vane JR
Fed Proc; 1979 Jan; 38(1):66-71. PubMed ID: 215463
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of action of dipyridamole.
Harker LA; Kadatz RA
Thromb Res Suppl; 1983; 4():39-46. PubMed ID: 6356465
[TBL] [Abstract][Full Text] [Related]
4. Effects of platelet-modifying drugs on arterial thromboembolism in baboons. Aspirin potentiates the antithrombotic actions of dipyridamole and sulfinpyrazone by mechanism(s) independent of platelet cyclooxygenase inhibition.
Hanson SR; Harker LA; Bjornsson TD
J Clin Invest; 1985 May; 75(5):1591-9. PubMed ID: 3923041
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of prostacyclin (PGI2), prostaglandin E1 and D2 on platelet aggregation in different species.
Whittle BJ; Moncada S; Vane JR
Prostaglandins; 1978 Sep; 16(3):373-88. PubMed ID: 364545
[TBL] [Abstract][Full Text] [Related]
6. Antithrombotic activity and the mechanism of action of trapidil (Rocornal).
Suzuki Y; Yamaguchi K; Shimada S; Kitamura Y; Ohnishi H
Prostaglandins Leukot Med; 1982 Dec; 9(6):685-95. PubMed ID: 6296885
[TBL] [Abstract][Full Text] [Related]
7. Prostacyclin (PGI2) and the effect of phosphodiesterase inhibitors on platelet aggregation.
Jørgensen KA; Dyerberg J; Stoffersen E
Pharmacol Res Commun; 1979 Jul; 11(7):605-15. PubMed ID: 388470
[No Abstract] [Full Text] [Related]
8. The role of prostacyclin and thromboxane A2 in the regulation of platelet behaviour.
Moncada S
Mater Med Pol; 1980; 12(3):207-12. PubMed ID: 7019591
[No Abstract] [Full Text] [Related]
9. Circulating prostacyclin.
Lancet; 1978 Jul; 2(8079):21-2. PubMed ID: 78214
[No Abstract] [Full Text] [Related]
10. A study of the stimulation of human venous prostacyclin synthesis by dipyridamole.
Jackson CA; Greaves M; Preston FE
Thromb Res; 1982 Sep; 27(5):563-73. PubMed ID: 6758183
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandins, platelets, and atherosclerosis.
Gryglewski RJ
CRC Crit Rev Biochem; 1980; 7(4):291-338. PubMed ID: 6771102
[TBL] [Abstract][Full Text] [Related]
12. The antithrombotic effect of aspirin and dipyridamole in relation to prostaglandin synthesis.
Louie S; Gurewich V
Thromb Res; 1983 May; 30(4):323-35. PubMed ID: 6351340
[TBL] [Abstract][Full Text] [Related]
13. Effects of low doses of aspirin and dipyridamole on platelet aggregation in the dog coronary artery.
Weselcouch EO; Humphrey WR; Aiken JW
J Pharmacol Exp Ther; 1987 Jan; 240(1):37-43. PubMed ID: 3543298
[TBL] [Abstract][Full Text] [Related]
14. Effect of dipyridamole and prostacyclin on rabbit platelet adherence in vitro and in vivo.
Groves HM; Kinlough-Rathbone RL; Cazenave JP; Dejana E; Richardson M; Mustard JF
J Lab Clin Med; 1982 Apr; 99(4):548-58. PubMed ID: 7038012
[TBL] [Abstract][Full Text] [Related]
15. Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis.
Schrör K
Semin Thromb Hemost; 1997; 23(4):349-56. PubMed ID: 9263351
[TBL] [Abstract][Full Text] [Related]
16. Effect of oral aspirin dose on platelet aggregation and vascular prostacyclin (PGI2) synthesis in humans and rabbits.
Ellis EF; Wright KF; Jones PS; Richardson DW; Ellis CK
J Cardiovasc Pharmacol; 1980; 2(4):387-97. PubMed ID: 6156337
[TBL] [Abstract][Full Text] [Related]
17. Differential inhibition of prostacyclin production and platelet aggregation by aspirin.
Masotti G; Galanti G; Poggesi L; Abbate R; Neri Serneri GG
Lancet; 1979 Dec; 2(8154):1213-7. PubMed ID: 92623
[No Abstract] [Full Text] [Related]
18. De-aggregatory action of prostacyclin in vivo and its enhancement by theophylline.
Gryglewski RJ; Korbut R; Ocetkiewicz A
Prostaglandins; 1978 Apr; 15(4):637-44. PubMed ID: 353903
[TBL] [Abstract][Full Text] [Related]
19. 10. Antithrombotic therapy: role of platelet-inhibitor drugs. II. Pharmacologic effects of platelet-inhibitor drugs (second of three parts).
Fuster V; Chesebro JH
Mayo Clin Proc; 1981 Mar; 56(3):185-95. PubMed ID: 7010003
[TBL] [Abstract][Full Text] [Related]
20. A biphasic effect of prostacyclin (PGI2) on platelet aggregation.
Jørgensen KA; Dyerberg J; Stoffersen E
Thromb Res; 1980 Sep; 19(6):877-81. PubMed ID: 6258262
[No Abstract] [Full Text] [Related]
[Next] [New Search]
